In the current report, a novel anti-human ICAM-1/CD54 scFv-Fc fusion protein (TP15-Fc) was identified by a cellular screening strategy intended to isolate antibodies for immunotherapy of MM from human phage libraries. The gene discussed is CDKN2B; the disease is Miyoshi myopathy.